Stock LPCN LIPOCINE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Lipocine Inc.

Equities

LPCN

US53630X2036

Market Closed - Nasdaq
Other stock markets
 21:30:00 21/05/2024 BST 		5-day change 1st Jan Change
6.57 USD +3.14% Intraday chart for Lipocine Inc. +22.80% +135.48%
05-09 Earnings Flash (LPCN) LIPOCINE Reports Q1 Revenue $7.6M MT
05-09 Lipocine Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
LIPOCINE INC. Stock Lipocine Inc.
 35.14M - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 114B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 107B
BIONTECH SE Stock BioNTech SE
 22.22B -
ARGENX SE Stock argenx SE
 21.28B -
BEIGENE, LTD. Stock BeiGene, Ltd.
 17.51B -
  1. Stock Market
  2. Equities
  3. LPCN Stock
  4. Charts Lipocine Inc.
  5. Sector Chart